Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Protocols for Central Venous Catheter-Related Infection in Hemodialysis Patients
IRCT20210921052544N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of taurolidine in catheter-associated bloodstream infection (CRBSI), Central venous catheter infection (CLABSI) and end-stage kidney disease (ESKD), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2022; status: completed.
02
Drugs
taurolidine
03
Conditions
catheter-associated bloodstream infection (CRBSI)Central venous catheter infection (CLABSI)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20210921052544N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210921052544N1.